Sheri Kashmir Institute of Medical Sciences Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2004
NCT00553072
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

epoetin (Epogen) (1 trial)

magnesium sulfate (Tis-U-Sol) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 1 Trials (1)

pralidoxime (protopam chloride) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asphyxia (Phase 3)

Asphyxia Neonatorum (Phase 3)

Organophosphate Poisoning (Phase 1)

Poisoning (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4